Insights On Trial Design

  1. Factors Affecting Systemic Drug Exposure 1/22/2025

    The increasing number of drugs on the market leads to a greater potential for DDIs. Determining the extent of the interaction and associated risks is an important safety consideration.

  2. Flexible Supply Strategies For Complex Clinical Trials 3/25/2026

    Explore how demand-led, decentralized clinical supply models are reshaping complex trials by reducing waste, accelerating timelines, and advancing patient-centric access to investigational therapies.

  3. Why Mobile Eye Exams Are Critical In Clinical Trials With Ocular Endpoints 1/29/2025

    Explore how mobile eye exams can expand access to eye care and improve the geographical reach of clinical trials.

  4. How The Right Meetings Make Patient-Centered Trial Design Possible 7/30/2025

    Including patients in trial design improves recruitment, retention, and site experience. Explore practical ways sponsors can gather early input—without disrupting timelines or adding complexity.

  5. Together, We Are On A Mission: Enabling Treatments To Reach Patients 4/22/2026

    This AI-powered digital clinical trials platform enhances speed, scale, and patient access in clinical research, accelerating medicines for thousands of conditions without treatment or cure.

  6. Ophthalmology Patient Engagement And Retention: Point-Of-Need Execution 4/6/2026

    Dropout in retinal trials is often a logistical failure. Reducing travel burden and bringing specialized care to the patient can slash attrition rates and secure critical trial timelines.

  7. Hybrid Ophthalmic Trials: Splitting Visits Across Home, Hub, And Site 12/23/2025

    Hybrid ophthalmic trials combine in-person and remote visits, boosting patient convenience, reducing site burden, and accelerating timelines while maintaining data quality and compliance.

  8. Strategies For Biomarker Development And Early Phase Clinical Studies 5/2/2025

    Companion diagnostics (CDx) are crucial for personalized medicine to enable precise patient selection for therapies. Explore biomarker development strategies and early-phase study considerations.

  9. Drug-Drug Interaction Study On A Novel Cardiovascular Medication 9/17/2024

    Learn how Altasciences leveraged its expertise to design, recruit, and conduct complex DDI studies, assessing pharmacokinetic and pharmacodynamic impacts of co-administered drugs.

  10. Obesity Clinical Research: Patient Recruitment Challenges 1/15/2026

    Obesity trials face enrollment hurdles. Learn how data-driven insights, patient-first strategies, and decentralized models can break barriers, ease burden, and accelerate timelines.